Global Canaloplasty
Market Report
2025
Canaloplasty Market Report 2025 (Global Edition)
The Global Canaloplasty Industry's Compound Annual Growth Rate will be 4.50% from 2023 to 2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Canaloplasty Market Report 2025.
Global Canaloplasty Market Report 2025 Market Size Split by Surgical Techniques (Ab-interno canaloplasty, Ab-Externo Canaloplasty), by End Use (Hospitals, Eye-care clinics, Specialty clinics, Others),...
The Global Canaloplasty Industry's Compound Annual Growth Rate will be 4.50% from 2023 to 2030.
| 2024 | 2025 | 2032 | 2033 | CAGR | |
|---|---|---|---|---|---|
| Global Canaloplasty Market Sales Revenue | 121212 | $ 632.5 Million | 121212 | $ 1145 Million | 7.7% |
| North America Canaloplasty Market Sales Revenue | 121212 | $ 244.4 Million | 121212 | $ 424.1 Million | 7.1% |
| United States Canaloplasty Market Sales Revenue | 121212 | $ 169.4 Million | 121212 | $ 285 Million | 6.7% |
| Mexico Canaloplasty Market Sales Revenue | 121212 | $ 18.6 Million | 121212 | $ 37.4 Million | 9.1% |
| Canada Canaloplasty Market Sales Revenue | 121212 | $ 56.4 Million | 121212 | $ 101.7 Million | 7.6% |
| Europe Canaloplasty Market Sales Revenue | 121212 | $ 197.6 Million | 121212 | $ 349.7 Million | 7.4% |
| France Canaloplasty Market Sales Revenue | 121212 | $ 29.2 Million | 121212 | $ 52.5 Million | 7.6% |
| Luxembourg Canaloplasty Market Sales Revenue | 121212 | $ 2.4 Million | 121212 | $ 3.5 Million | 5% |
| Germany Canaloplasty Market Sales Revenue | 121212 | $ 35.6 Million | 121212 | $ 65.7 Million | 8% |
| Spain Canaloplasty Market Sales Revenue | 121212 | $ 19 Million | 121212 | $ 30.1 Million | 5.9% |
| United Kingdom Canaloplasty Market Sales Revenue | 121212 | $ 47.4 Million | 121212 | $ 89.5 Million | 8.3% |
| Russia Canaloplasty Market Sales Revenue | 121212 | $ 9.5 Million | 121212 | $ 15.7 Million | 6.5% |
| Italy Canaloplasty Market Sales Revenue | 121212 | $ 18.6 Million | 121212 | $ 30.8 Million | 6.5% |
| Rest of Europe Canaloplasty Market Sales Revenue | 121212 | $ 24.7 Million | 121212 | $ 44.4 Million | 7.6% |
| Asia Pacific Canaloplasty Market Sales Revenue | 121212 | $ 146.1 Million | 121212 | $ 287.4 Million | 8.8% |
| South East Asia Canaloplasty Market Sales Revenue | 121212 | $ 4.9 Million | 121212 | $ 9 Million | 8% |
| China Canaloplasty Market Sales Revenue | 121212 | $ 61.5 Million | 121212 | $ 126.9 Million | 9.5% |
| Australia Canaloplasty Market Sales Revenue | 121212 | $ 10.6 Million | 121212 | $ 19.4 Million | 7.9% |
| South Korea Canaloplasty Market Sales Revenue | 121212 | $ 17 Million | 121212 | $ 32.9 Million | 8.6% |
| India Canaloplasty Market Sales Revenue | 121212 | $ 18.8 Million | 121212 | $ 41.6 Million | 10.4% |
| Japan Canaloplasty Market Sales Revenue | 121212 | $ 30.2 Million | 121212 | $ 52.8 Million | 7.2% |
| Rest of APAC Canaloplasty Market Sales Revenue | 121212 | $ 3.2 Million | 121212 | $ 4.8 Million | 5.3% |
| South America Canaloplasty Market Sales Revenue | 121212 | $ 24.7 Million | 121212 | $ 45.8 Million | 8% |
| Argentina Canaloplasty Market Sales Revenue | 121212 | $ 3.9 Million | 121212 | $ 6.9 Million | 7.5% |
| Brazil Canaloplasty Market Sales Revenue | 121212 | $ 12 Million | 121212 | $ 21.9 Million | 7.8% |
| Chile Canaloplasty Market Sales Revenue | 121212 | $ 3 Million | 121212 | $ 5.7 Million | 8.4% |
| Peru Canaloplasty Market Sales Revenue | 121212 | $ 1.7 Million | 121212 | $ 3.4 Million | 9% |
| Colombia Canaloplasty Market Sales Revenue | 121212 | $ 2.3 Million | 121212 | $ 4.7 Million | 9.4% |
| Rest of South America Canaloplasty Market Sales Revenue | 121212 | $ 1.9 Million | 121212 | $ 3.3 Million | 7.1% |
| Middle East and Africa Canaloplasty Market Sales Revenue | 121212 | $ 19.7 Million | 121212 | $ 38 Million | 8.5% |
| Egypt Canaloplasty Market Sales Revenue | 121212 | $ 2.3 Million | 121212 | $ 4.4 Million | 8.1% |
| Turkey Canaloplasty Market Sales Revenue | 121212 | $ 3.8 Million | 121212 | $ 7.2 Million | 8.3% |
| Rest of MEA Canaloplasty Market Sales Revenue | 121212 | $ 1.7 Million | 121212 | $ 3 Million | 7.4% |
| Base Year | 2024 |
| Historical Data Time Period | 2021-2024 |
| Forecast Period | 2025-2033 |
| Market Split by Surgical Techniques |
|
| Market Split by End Use |
|
| Market Split by Indications |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Canaloplasty industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Canaloplasty Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Canaloplasty Market Report Description
Introduction of Canaloplasty
Increase in prevalence of glaucoma, limited efficiency of eye drops and medications, technological advancements in surgical techniques, long-term reduction of diseases, technological advancements in medical tools and devices, increasing awareness about glaucoma among people and healthcare professionals, improvement in healthcare infrastructure, rise in healthcare expenditure, increasing aged-population and government support and measures are the factors driving the Canaloplasty market growth.
These developments empower businesses to offer better-tailored solutions and services, which, in turn, contribute to the growth of the Canaloplasty industry.
- For instance, More than 3 million Americans are living with glaucoma, 2.7 million of whom (aged 40 and older) are affected by its most common form, open-angle glaucoma.
(Source:www.brightfocus.org/glaucoma/article/glaucoma-facts-figures)
Canaloplasty Market Size
What are the Drivers Influencing the Growth of the Canaloplasty Market?
Increasing Initiatives by the Government to Provide Viable Market Output
A significant market driver for Canaloplasty has been the rise in government initiatives. As governments increasingly prioritize healthcare enhancement, their support fosters market growth. Financial backing for research and development activities related to canaloplasty techniques and devices significantly accelerates innovation, resulting in advanced and efficient treatment options. Moreover, regulatory bodies working with governments ensure quicker approvals, reducing market entry barriers for new technologies. Government awareness campaigns focus on educating healthcare professionals and the public about the benefits of canaloplasty.
- Governments launched a new resolution at the United Nations General Assembly to achieve greater efforts to make eye care services an essential part of universal health coverage and address the rising impact of vision loss on sustainable development.
Collaborations between public institutions and private manufacturers stimulate market expansion by encouraging knowledge exchange and technology transfer. Government initiatives provide the necessary impetus for research, development, accessibility, and acceptance of canaloplasty procedures and products, propelling the global market forward.
The Factors are Restricting Growth of Canaloplasty Market
Limited Awareness Among Patients of Hinder Market Growth
The constraints of limited awareness among patients and healthcare providers about the procedure's benefits, complex surgical techniques requiring specialized skills, and competition from established glaucoma treatment methods constrain the Canaloplasty market. Additionally, regulatory hurdles and reimbursement issues might hinder market expansion. Despite canaloplasty's potential for reducing intraocular pressure, addressing these challenges is crucial for its wider adoption and sustained growth in the ophthalmic medical field.
Impact Of COVID-19 on the Canaloplasty Market
Lockdowns and safety concerns hindered patient access to treatment facilities. However, as restrictions eased, the market showed signs of recovery with a renewed focus on minimally invasive procedures and increased adoption of telemedicine for consultations. Manufacturers and healthcare providers adapted to the new normal by implementing stringent safety protocols. The market's trajectory is gradually improving as healthcare systems stabilize and patient confidence returns, with a heightened emphasis on innovation and patient-centered care driving future growth.
We have various report editions of Canaloplasty Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Canaloplasty Market Insights Video
Competitive Landscape of Canaloplasty Market
The market for Canaloplasty features intense competition among key players. Innovations in surgical techniques and advanced medical technologies drive the market's growth. Additionally, focusing on product differentiation, clinical efficacy, and regulatory compliance remains crucial. With a growing patient preference for minimally invasive procedures, the market is anticipated to witness sustained rivalry, fostering advancements and improved patient outcomes.
Canaloplasty Industry News
- April 2022: Nova Eye Medical Limited, a medical technology company dedicated to breakthrough ophthalmic treatment technologies and devices, today announced the launch of its next-generation canaloplasty device, iTrack Advance, in select European and Asia Pacific regions.
- April 2022: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on therapies for the treatment of glaucoma, corneal disorders, retinal diseases and eye diseases, propounded that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery annual meeting, which was held in Washington, D.C., from April 22-26, 2022.
- March 2021: Sight Sciences, Inc., a growth-stage Medical Device company focused on addressing the underlying causes of the world's most common eye conditions, announced today that the OMNI Surgical System (OMNI) has received USFDA 510(k) clearance for canaloplasty (microcatheterization and transluminal vasodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce Intraocular Pressure (IOP).
Top Companies Market Share in Canaloplasty Industry: (In no particular order of Rank)
- Glaukos Corporation
- iStar Medical SA
- LUMIBIRD
- Lumenis Ltd
- New World Medical
- Inc.
- Santen Pharmaceutical Co. Ltd
- Topcon Corporation
- Sight Sciences
- Inc.
- Nova Eye Medical Limited
- ASICO
- LLC.
- Carl Zeiss Meditec AG
- Alcon
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North American Canaloplasty Market Dominate the Largest Share of Global Market
According to Cognitive Market Research, North America dominated the market in 2022. It accounted for a share of more than 30% of the global revenue due to increasing cases of glaucoma and the aging population. The North American region dominates the market for Canaloplasty. The region's advanced healthcare infrastructure, technological innovations, and skilled medical professionals contribute to adopting canaloplasty procedures. Additionally, rising awareness about minimally invasive treatments and their benefits drives market expansion. According to Cognitive Market Research, the United States is anticipated to hold a strong position in the North American area due to the increase in acceptance of treatment options. Major economies like the United States and Canada are at the forefront of this growth, supported by favorable reimbursement policies. However, competition from alternative glaucoma treatment methods and regulatory considerations remain factors influencing market dynamics in the North American canaloplasty sector.
Regarding market dynamics, the North American canaloplasty market has witnessed collaborations between medical device companies and healthcare providers, increasing accessibility and awareness about the procedure. Ongoing research and clinical trials have aimed to optimize the technique, making it more efficient and patient-friendly. The availability of skilled ophthalmic surgeons and state-of-the-art medical facilities has contributed to the success of canaloplasty as a viable glaucoma treatment. Moreover, the FDA's approval of canaloplasty devices and growing insurance coverage for the procedure have further facilitated its uptake.
The current report Scope analyzes Canaloplasty Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Canaloplasty Market Share (%) by Region (2021-2033)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Canaloplasty
As per the current market study, out of 632.5 Million USD global market revenue 2025, North America market holds 38.64% of the market share. The North America Canaloplasty industry grew from 185.4 Million USD in 2021 to 244.4 Million USD in 2025 and will record 75.86% growth. In coming future this industry will reach 424.1 Million by 2033 with a 7.1% CAGR. If we look at the percentage market shares of top North America countries for 2025,United States (69.31%), Mexico (7.61%), Canada (23.08%)
Europe Canaloplasty
As per the current market study, out of 632.5 Million USD global market revenue 2025, Europe market holds 31.24% of the market share. The Europe Canaloplasty industry grew from 148.7 Million USD in 2021 to 197.6 Million USD in 2025 and will record 75.25% growth. In coming future this industry will reach 349.7 Million by 2033 with a 7.4% CAGR. If we look at the percentage market shares of top Europe countries for 2025,France (14.78%), Luxembourg (1.21%), Germany (18.02%), Spain (9.62%), United Kingdom (23.99%), Russia (4.81%), Italy (9.41%), Rest of Europe (12.50%)
Asia Pacific Canaloplasty
As per the current market study, out of 632.5 Million USD global market revenue 2025, Asia Pacific market holds 23.10% of the market share. The Asia Pacific Canaloplasty industry grew from 103.9 Million USD in 2021 to 146.1 Million USD in 2025 and will record 71.12% growth. In coming future this industry will reach 287.4 Million by 2033 with a 8.8% CAGR. If we look at the percentage market shares of top Asia Pacific countries for 2025,South East Asia (3.35%), China (42.09%), Australia (7.26%), South Korea (11.64%), India (12.87%), Japan (20.67%), Rest of APAC (2.19%)
South America Canaloplasty
As per the current market study, out of 632.5 Million USD global market revenue 2025, South America market holds 3.91% of the market share. The South America Canaloplasty industry grew from 17.9 Million USD in 2021 to 24.7 Million USD in 2025 and will record 72.47% growth. In coming future this industry will reach 45.8 Million by 2033 with a 8% CAGR. If we look at the percentage market shares of top South America countries for 2025,Argentina (15.79%), Brazil (48.58%), Chile (12.15%), Peru (6.88%), Colombia (9.31%), Rest of South America (7.69%)
Middle East and Africa Canaloplasty
As per the current market study, out of 632.5 Million USD global market revenue 2025, Middle East and Africa market holds 3.11% of the market share. The Middle East and Africa Canaloplasty industry grew from 14.2 Million USD in 2021 to 19.7 Million USD in 2025 and will record 72.08% growth. In coming future this industry will reach 38 Million by 2033 with a 8.5% CAGR. If we look at the percentage market shares of top Middle East and Africa countries for 2025,Egypt (11.68%), Turkey (19.29%), Rest of MEA (8.63%)
Canaloplasty Market Analysis
Global Canaloplasty Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Canaloplasty Industry growth. Canaloplasty market has been segmented with the help of its Surgical Techniques, End Use Indications, and others. Canaloplasty market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By Surgical Techniques, the Ab-interno canaloplasty Segment Dominate the Canaloplasty Market
The Ab-interno canaloplasty is the Canaloplasty market's most popular technique. It involves performing the procedure from within the eye. It utilizes microsurgical tools to create a microscopic incision, allowing for the delicate manipulation and dilation of the eye's natural drainage channels. This technique offers several advantages, such as reduced postoperative complications, faster recovery, and minimal trauma to surrounding tissues.
According to Cognitive Market Research, Ab-externo canaloplasty is the second-most popular technique performed externally. It involves making a small incision in the eye's outer layers to access and enhance its drainage system. While this technique might require a slightly longer recovery period due to the external incision, it remains an effective option for managing glaucoma and improving drainage.
- GlaucomaAb-interno canaloplasty
- Ab-Externo Canaloplasty
Canaloplasty Market Share (%) by Surgical Techniques in 2021-2033
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Canaloplasty Industry. Request a Free Sample PDF!
By End Use, the Hospitals Segment Dominate the Canaloplasty Market
According to Cognitive Market Research, hospitals, notably, are the dominant end-user in the Canaloplasty market due to their comprehensive medical infrastructure and ability to offer a wide range of ophthalmic procedures. Hospitals provide a one-stop solution for patients' medical needs and often house specialized ophthalmology departments that can handle complex canaloplasty surgeries. Their established reputation for high-quality healthcare services and the availability of advanced equipment attract patients seeking effective and reliable treatments.
The Eye-clinics have also gained prominence in the Canaloplasty market. These clinics focus exclusively on ophthalmic treatments, allowing them to develop expertise in eye-related procedures, including canaloplasty. Their specialized nature ensures that patients receive targeted care from professionals well-versed in the latest advancements in ophthalmology.
- Hospitals
- Eye-care clinics
- Specialty clinics
- Others
Canaloplasty Market Share (%) by End Use in 2021-2033
2021
2025
2033
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Canaloplasty Indications Segment Analysis
Global Canaloplasty market by Indications segment analysis
According to Cognitive Market Research, glaucoma treatment is the primary segment under indication for the Canaloplasty market. Canaloplasty offers a minimally invasive surgical solution for managing glaucoma by enhancing the eye's natural drainage pathway. This procedure involves dilation and reconstruction of the Schlemm's canal, reducing intraocular pressure and preserving vision. The prevalence of glaucoma and the demand for advanced treatments drive the growth of this market segment. Canaloplasty's effectiveness in improving the quality of life for glaucoma patients makes it a pivotal player in the ophthalmic medical landscape.
- Glaucoma
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Canaloplasty Market is witnessing significant growth in the near future.
In 2023, the Ab-interno canaloplasty segment accounted for noticeable share of global Canaloplasty Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Glaukos Corporation , LUMIBIRD and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Canaloplasty Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Canaloplasty Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Surgical Techniques | Ab-interno canaloplasty, Ab-Externo Canaloplasty |
| End Use | Hospitals, Eye-care clinics, Specialty clinics, Others |
| Indications | Glaucoma |
| List of Competitors | Glaukos Corporation, iStar Medical SA, LUMIBIRD, Lumenis Ltd, New World Medical, Inc., Santen Pharmaceutical Co. Ltd, Topcon Corporation, Sight Sciences, Inc., Nova Eye Medical Limited, ASICO, LLC., Carl Zeiss Meditec AG, Alcon |
This chapter will help you gain GLOBAL Market Analysis of Canaloplasty. Further deep in this chapter, you will be able to review Global Canaloplasty Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Canaloplasty Revenue Market Size, Trend Analysis 2021 - 2033
-
1.2 Global Canaloplasty Market Size By Regions 2021 - 2033
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Canaloplasty Revenue Market Size By Region
-
-
1.3 Global Canaloplasty Market Size By Surgical Techniques 2021 - 2033
-
1.3.1 Ab-interno canaloplasty Market Size
-
1.3.2 Ab-Externo Canaloplasty Market Size
-
-
1.4 Global Canaloplasty Market Size By End Use 2021 - 2033
-
1.4.1 Hospitals Market Size
-
1.4.2 Eye-care clinics Market Size
-
1.4.3 Specialty clinics Market Size
-
1.4.4 Others Market Size
-
-
1.5 Global Canaloplasty Market Size By Indications 2021 - 2033
-
1.5.1 Glaucoma Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
-
1.7.2 Global Market Revenue Split By Surgical Techniques
-
1.7.3 Global Market Revenue Split By End Use
-
1.7.4 Global Market Revenue Split By Indications
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Canaloplasty. Further deep in this chapter, you will be able to review North America Canaloplasty Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Canaloplasty Market Size 2021 - 2033
-
2.1.1 North America Canaloplasty Market Size By Country 2021 - 2033
-
2.1.2 North America Canaloplasty Market Size by Surgical Techniques 2021 - 2033
-
2.1.2.1 North America Ab-interno canaloplasty Market Size
-
2.1.2.2 North America Ab-Externo Canaloplasty Market Size
-
-
2.1.3 North America Canaloplasty Market Size by End Use 2021 - 2033
-
2.1.3.1 North America Hospitals Market Size
-
2.1.3.2 North America Eye-care clinics Market Size
-
2.1.3.3 North America Specialty clinics Market Size
-
2.1.3.4 North America Others Market Size
-
-
2.1.4 North America Canaloplasty Market Size by Indications 2021 - 2033
-
2.1.4.1 North America Glaucoma Market Size
-
-
This chapter will help you gain Europe Market Analysis of Canaloplasty. Further deep in this chapter, you will be able to review Europe Canaloplasty Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Canaloplasty Market Size 2021 - 2033
-
3.1.1 Europe Canaloplasty Market Size By Country 2021 - 2033
-
3.1.2 Europe Canaloplasty Market Size by Surgical Techniques 2021 - 2033
-
3.1.2.1 Europe Ab-interno canaloplasty Market Size
-
3.1.2.2 Europe Ab-Externo Canaloplasty Market Size
-
-
3.1.3 Europe Canaloplasty Market Size by End Use 2021 - 2033
-
3.1.3.1 Europe Hospitals Market Size
-
3.1.3.2 Europe Eye-care clinics Market Size
-
3.1.3.3 Europe Specialty clinics Market Size
-
3.1.3.4 Europe Others Market Size
-
-
3.1.4 Europe Canaloplasty Market Size by Indications 2021 - 2033
-
3.1.4.1 Europe Glaucoma Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of Canaloplasty. Further deep in this chapter, you will be able to review Asia Pacific Canaloplasty Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Canaloplasty Market Size 2021 - 2033
-
4.1.1 Asia Pacific Canaloplasty Market Size By Country 2021 - 2033
-
4.1.2 Asia Pacific Canaloplasty Market Size by Surgical Techniques 2021 - 2033
-
4.1.2.1 Asia Pacific Ab-interno canaloplasty Market Size
-
4.1.2.2 Asia Pacific Ab-Externo Canaloplasty Market Size
-
-
4.1.3 Asia Pacific Canaloplasty Market Size by End Use 2021 - 2033
-
4.1.3.1 Asia Pacific Hospitals Market Size
-
4.1.3.2 Asia Pacific Eye-care clinics Market Size
-
4.1.3.3 Asia Pacific Specialty clinics Market Size
-
4.1.3.4 Asia Pacific Others Market Size
-
-
4.1.4 Asia Pacific Canaloplasty Market Size by Indications 2021 - 2033
-
4.1.4.1 Asia Pacific Glaucoma Market Size
-
-
This chapter will help you gain South America Market Analysis of Canaloplasty. Further deep in this chapter, you will be able to review South America Canaloplasty Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Canaloplasty Market Size 2021 - 2033
-
5.1.1 South America Canaloplasty Market Size By Country 2021 - 2033
-
5.1.2 South America Canaloplasty Market Size by Surgical Techniques 2021 - 2033
-
5.1.2.1 South America Ab-interno canaloplasty Market Size
-
5.1.2.2 South America Ab-Externo Canaloplasty Market Size
-
-
5.1.3 South America Canaloplasty Market Size by End Use 2021 - 2033
-
5.1.3.1 South America Hospitals Market Size
-
5.1.3.2 South America Eye-care clinics Market Size
-
5.1.3.3 South America Specialty clinics Market Size
-
5.1.3.4 South America Others Market Size
-
-
5.1.4 South America Canaloplasty Market Size by Indications 2021 - 2033
-
5.1.4.1 South America Glaucoma Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of Canaloplasty. Further deep in this chapter, you will be able to review Middle East and Africa Canaloplasty Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Canaloplasty Market Size 2021 - 2033
-
6.1.1 Middle East and Africa Canaloplasty Market Size By Country 2021 - 2033
-
6.1.2 Middle East and Africa Canaloplasty Market Size by Surgical Techniques 2021 - 2033
-
6.1.2.1 Middle East and Africa Ab-interno canaloplasty Market Size
-
6.1.2.2 Middle East and Africa Ab-Externo Canaloplasty Market Size
-
-
6.1.3 Middle East and Africa Canaloplasty Market Size by End Use 2021 - 2033
-
6.1.3.1 Middle East and Africa Hospitals Market Size
-
6.1.3.2 Middle East and Africa Eye-care clinics Market Size
-
6.1.3.3 Middle East and Africa Specialty clinics Market Size
-
6.1.3.4 Middle East and Africa Others Market Size
-
-
6.1.4 Middle East and Africa Canaloplasty Market Size by Indications 2021 - 2033
-
6.1.4.1 Middle East and Africa Glaucoma Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Canaloplasty Market Size by Surgical Techniques 2021 - 2033
-
7.1.2 Country 1Canaloplasty Market Size by End Use 2021 - 2033
-
7.1.3 Country 1Canaloplasty Market Size by Indications 2021 - 2033
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of Canaloplasty. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2023
-
8.1.2 Global Canaloplasty Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability) Sample Format
-
8.2.1 Glaukos Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 iStar Medical SA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 LUMIBIRD
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Lumenis Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 New World Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Santen Pharmaceutical Co. Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Topcon Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Sight Sciences
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Nova Eye Medical Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 ASICO
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 LLC.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 Carl Zeiss Meditec AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Alcon
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Surgical Techniques Analysis 2019 -2031, will provide market size split by Surgical Techniques. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Surgical Techniques Analysis 2021 - 2033
-
10.1 Ab-interno canaloplasty
-
10.1.1 Global Canaloplasty Revenue Market Size and Share by Ab-interno canaloplasty 2021 - 2033
-
-
10.2 Ab-Externo Canaloplasty
-
10.2.1 Global Canaloplasty Revenue Market Size and Share by Ab-Externo Canaloplasty 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End Use Analysis 2021 - 2033
-
11.1 Hospitals
-
11.1.1 Global Canaloplasty Revenue Market Size and Share by Hospitals 2021 - 2033
-
-
11.2 Eye-care clinics
-
11.2.1 Global Canaloplasty Revenue Market Size and Share by Eye-care clinics 2021 - 2033
-
-
11.3 Specialty clinics
-
11.3.1 Global Canaloplasty Revenue Market Size and Share by Specialty clinics 2021 - 2033
-
-
11.4 Others
-
11.4.1 Global Canaloplasty Revenue Market Size and Share by Others 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Indications Analysis 2021 - 2033
-
12.1 Glaucoma
-
12.1.1 Global Canaloplasty Revenue Market Size and Share by Glaucoma 2021 - 2033
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Canaloplasty market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1 Data Gathering
- 1.1 Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.1.1.1 Identification of KOL
- 1.1.1.2 Backward Integration
- 1.1.1.3 Forward Integration
- 1.1.1.4 How Primary Research Help Us
- 1.1.1.5 Modes of Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.2 Secondary Research
- 1.2.1 How Secondary Research Help Us
- 1.2.2 Sources of Secondary Research
- 1.1 Primary Research
- 2 Data Validation
- 2.1 Cross check KOL Responses with Secondary Data
- 2.2 Top Down & Bottom Up Approach
- 2.3 Data Triangulation
- 3 Data Representation
Key Questions Answered By Canaloplasty Market Report 2025
| Why Ab-interno canaloplasty have a significant impact on Canaloplasty market? |
| What are the key factors affecting the Ab-interno canaloplasty and Ab-Externo Canaloplasty of Canaloplasty Market? |
| What is the CAGR/Growth Rate of Hospitals during the forecast period? |
| By type, which segment accounted for largest share of the global Canaloplasty Market? |
| Which region is expected to dominate the global Canaloplasty Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
